Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases.
Middleton LP, Price KM, Puig P, Heydon LJ, Tarco E, Sneige N, Barr K, Deavers MT
Purpose
The aim of this paper was to assess concordance among HER-2 fluorescence in situ hybridization (FISH) and immunohistochemistry results before and after implementation of the American Society of Clinical Oncology/College of American Pathologists guideline recommendations for HER-2 analysis.
Conclusion
Implementation of guideline recommendations for HER-2 analysis, and thereby standardizing the duration of formalin fixation to a minimum of 6 h for biopsy specimens, resulted in a modest increase in FISH and immunohistochemistry concordance (from 98% to 98.5%) and a significant decrease in the number of FISH inconclusive cases (from 10.8% to 3.4%).
Studies (1)
Purpose
The purpose of this study was to assess concordance among HER-2 results by FISH and immunohistochemistry before and after implementation of the American Society of Clinical Oncology/College of American Pathologists guideline recommendations. Formalin-fixed, paraffin-embedded core breast needle biopsies were used for analysis.
Summary of Findings
A retrospective analysis of specimens procured and assessed for HER-2 prior to the publication of the guidelines revealed a 98% concordance among results of FISH and immunohistochemistry, and an additional 10.8% of cases that produced inconclusive FISH results. The majority of cases which yielded inconclusive results were retrospectively correlated to the time of day specimens were submitted to pathology (after 2 pm) and the duration of formalin fixation (an average of 4 h). Standardization of fixation time to a minimum of 6 h via improved annotation and use of an automated processor resulted in a significant decrease in the number of FISH inconclusive cases from 10.8% to 3.4% as well as an increase among FISH and immunohistochemistry concordance from 98% to 98.5%.
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryDNAFISHPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Time in fixative 4 h6 h